Clinical Trial Update: A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing three apremilast tablet formulations taken with or without food in healthy volunteers was terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: TERMINATED | Results posted: 2023-08-31